Trent R. Percy
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Moffitt Cancer Center (2020–2021); Molecular Oncology (United States) (2020–2021)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Trent R. Percy's research investigates molecular mechanisms underlying lung cancer, with a focus on identifying potential therapeutic targets. His work has explored the synergistic effects of drug combinations, such as CDK4/6 inhibition combined with targeting P21-Activated Kinases (PAKs) in lung cancer cell lines. Percy has also studied the role of CX3CL1 expression loss in mediating immune evasion in lung adenocarcinomas with specific mutations, such as STK11. His research has utilized cell line models and examined aspects of gene expression regulation in neoplastic cells. Percy has published three works with a total of ten citations and holds an h-index of 2, indicating recent activity in his field.
Metrics
- h-index: 2
- Publications: 3
- Citations: 10
Selected Publications
-
Abstract 4454: Loss of CX3CL1 expression mediates immune evasion in <i>STK11</i> mutated lung adenocarcinomas (2023)
Collaboration Network
Top Collaborators
- Abstract 4454: Loss of CX3CL1 expression mediates immune evasion in <i>STK11</i> mutated lung adenocarcinomas
- Abstract 4454: Loss of CX3CL1 expression mediates immune evasion in <i>STK11</i> mutated lung adenocarcinomas
- Abstract 4454: Loss of CX3CL1 expression mediates immune evasion in <i>STK11</i> mutated lung adenocarcinomas
- Abstract 4454: Loss of CX3CL1 expression mediates immune evasion in <i>STK11</i> mutated lung adenocarcinomas
Similar Researchers
Based on overlapping research topics